Quotient Investors’s Vaxart VXRT Stock Holding History

Quotient Investors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,555	Closed	-$49K	–	288
2014 Q2	$49K	Buy	+1,555	New	+$65K	0.01%	251

Other funds holding VXRT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quotient Investors's VXRT Position: Q3 2014 in Review

Quotient Investors sold out of Vaxart (VXRT) in Q3 2014, closing a stake of 1,555 shares — an estimated $49K sold.

Quotient Investors first reported a position in VXRT in Q2 2014 and held it in 1 quarter. The position peaked at $49K in Q2 2014. 49 funds tracked by Wall St. Rank hold VXRT as of Q3 2014.

Quotient Investors reported no remaining Vaxart position as of Q3 2014 after selling out during the quarter.
Quotient Investors sold 1,555 Vaxart shares in Q3 2014, an estimated $49K.
Quotient Investors first reported a position in Vaxart in Q2 2014 and held it in 1 quarter.
Quotient Investors's Vaxart position peaked at $49K in Q2 2014.
49 funds tracked by Wall St. Rank held Vaxart as of Q3 2014.

Based on Quotient Investors's 13F filing for Q3 2014, filed 14 Oct 2014.